Today’s list has one speculative fintech buy, one catalyst-driven biotech buy, and one beaten-down software buy. The key is knowing which story deserves a small position and which one looks strongest on fundamentals.

Turning Heads (Sponsored)

A little-known opportunity averaging 29% annually is finally getting attention outside Wall Street.

While traditional savings accounts struggle to keep up with inflation, this strategy has quietly compounded wealth for years.

Discover how “The 29% Account” works in this free presentation today.

Futures at a Glance📈

Futures are ticking higher as traders digest a more hawkish Fed message without fully backing away from risk. Nasdaq names are leading the rebound, while South Korea and Japan hit fresh records overnight. The big question now is whether stronger global momentum can outweigh rate-hike jitters as jobless claims, Philly Fed data, and earnings from Accenture and Kroger hit the tape.

Want to make sure you never miss a pre-market alert?

Elite Trade Club now offers text alerts — so you get trending stocks and market-moving news sent straight to your phone before the bell.

Email’s great. Texts are faster.

You’ll be first in line when the market starts moving.

What to Watch

Earnings (Premarket):
• Accenture plc [ACN]
• Kroger Company (The) [KR]

Earnings (Time Not Supplied):
• Chart Industries, Inc. [GTLS]
• Telix Pharmaceuticals Limited [TLX]
• Hub Group, Inc. [HUBG]

Economic Reports:
• Weekly Jobless Claims (Jun. 13): 8:30 am
• Philadelphia Fed Business Outlook Survey (Jun.): 8:30 am
• Leading Indicators (May): 10:00 am

Elite Trade Club Insider

$75 Million In Insider Selling Just Hit Two AI Hardware Winners

You’re seeing the AI infrastructure boom from the outside, where every strong chart looks like another reason to chase. But Elite Trade Club Insider readers are getting the part the crowd usually sees too late: executives are turning massive rallies into cash while the headlines still sound bullish.

You’re reading the free version. Here’s what we held back.

Every day, insiders and institutions move millions before the market catches on. We surface the data behind those moves before the rest of the market sees it.

A subscription gets you:

  • The insider buys, options bets, and dark pool moves the free edition can't show you. Unlocked every weekday.

  • A Sunday Deep Dive that tells you where to look before Monday's bell rings.

  • The Friday Smart Money Brief: who bought, who sold, where the big options bets landed, and where institutions are hiding volume. Three data layers. One email.

  • A Monthly Insider Scorecard so you always know whether smart money is buying or selling the market.

  • Every past Insider edition, unlocked, on elitetrade.club. Go back and see what you missed.

$25/mo or $250/yr. 30-day money back guarantee. Cancel anytime. Founding member pricing: lock in $25/mo before we raise it.

Fintech

Robinhood Markets Is More Than a SpaceX IPO Pop

Robinhood Markets Inc (NASDAQ: HOOD) got a fresh spotlight after being one of five brokerages chosen to offer retail access to the SpaceX IPO. The stock is still about 36% below its highs, but it has gained more than 6% since the IPO.

That access matters because it fits Robinhood’s core pitch: give retail investors entry into markets usually reserved for institutions. IPO access without a minimum balance or net worth requirement is exactly the kind of feature that can bring new users onto the platform.

The bigger story is that Robinhood is expanding beyond basic trading. It is moving into credit cards, bank accounts, prediction markets, crypto, and now underwriting after receiving approval to underwrite stocks.

That is a major step. Underwriting puts Robinhood closer to investment banking territory, which adds a more traditional financial-services lane to a business still heavily tied to volatile trading activity.

The risk is real. Crypto revenue fell 47% year over year in the first quarter, and Bitcoin’s weakness has weighed on sentiment. Prediction markets revenue jumped 320%, but that business is also volatile.

Still, Robinhood has the right kind of product momentum for a risk-tolerant investor. At around 51x earnings, the stock is not cheap, but the company is building more ways to keep users inside its ecosystem.

My Take For You: Robinhood is still risky, but SpaceX access, underwriting approval, and product expansion give the stock more than one path to growth.

My Verdict: Buy this, but keep the position small. The risk is that crypto weakness and volatile trading revenue overwhelm progress in newer products.

Biotech

Moderna Gets the FDA Setup Bulls Needed

Moderna Inc (NASDAQ: MRNA) jumped after the FDA released broadly favorable briefing documents for its mRNA-based flu vaccine candidate, mFlusiva. Shares rose more than 11% and hit a new 52-week high of $62.30.

The rally makes sense. The FDA documents found no major deficiencies in Moderna’s regulatory filing ahead of a key advisory committee meeting. That was a relief after the agency issued a rare refuse-to-file letter earlier this year over trial design concerns in older adults.

Moderna has since adjusted its strategy. The company is seeking traditional approval for adults ages 50 to 64 and accelerated approval for adults 65 and older, based on immunogenicity data.

The next major catalyst is the VRBPAC advisory committee vote. After that, investors will be watching the FDA’s target action date on August 5, 2026.

This matters beyond one flu shot. A positive outcome would strengthen Moderna’s broader mRNA vaccine platform and support its push beyond COVID-19 revenue.

It could also help the path for mCombriax, Moderna’s combination flu and COVID vaccine already approved in the EU. That gives investors a cleaner diversification story.

My Take For You: Moderna finally has a catalyst that can rebuild confidence in its post-COVID pipeline.

My Verdict: Buy this. The risk is that the advisory vote or final FDA decision disappoints after the stock’s sharp year-to-date rebound.

Income Strategy (Sponsored)

His official paycheck? $400,000 a year.

But the real story is somewhere else: As much as $250,000 per month… from a single source.

It’s not real estate. It’s not the stock market.

So what’s actually producing this level of cash flow and why are more investors turning to it today?

Discover how to get started for less than $20.

Enterprise Software

Salesforce Looks Too Cheap for This Much Cash Flow

Salesforce Inc (NYSE: CRM) is still being treated like an AI disruption victim, even after a strong quarter. The stock is down more than 40% over the past year and recently touched a new 52-week low.

The numbers do not look broken. Revenue rose 13% year over year to $11.13 billion, while non-GAAP EPS came in at $3.88 versus expectations near $3.12. Free cash flow reached $6.6 billion in the quarter.

Margins are also moving in the right direction. GAAP operating margin hit 21.1%, and non-GAAP operating margin reached 34.8%, up from 32.3% a year earlier.

The market’s concern is the business model. Salesforce built its empire on seat-based software subscriptions, and investors are asking whether AI agents will eventually reduce the need for those seats.

Salesforce is answering with Agentforce. The company is trying to charge for AI work completed, not just human users logged into software. Agentforce ARR reached $1.2 billion in Q1, up 205% year over year.

That is not a side project anymore. Combined AI and data ARR reached $3.4 billion, and more than half of Agentforce and Data 360 bookings came from existing customers.

At under 18x earnings, Salesforce is priced like a slower software company. But the cash flow, margins, cRPO growth, and AI traction argue the market has gone too negative.

My Take For You: Salesforce is being punished for AI risk while already building a real AI revenue stream.

My Verdict: Buy this. The risk is that Agentforce adoption grows, but not fast enough to offset pressure on the traditional seat-based model.

Movers and Shakers

Rumble [RUM]: Premarket Move: +16%

Rumble is moving higher after announcing its rebrand to RUM Group Inc. and renaming its cloud unit Quake AI. The move follows the close of its Northern Data acquisition, which gives the company a much bigger AI-infrastructure story.

The numbers are the reason traders care. Quake AI now combines Rumble Cloud with roughly 22,000 NVIDIA H100/H200 GPUs across nine data centers, plus about 250 MW of energized and planned power capacity. Northern Data also raised its 2026 revenue outlook to €170 million to €190 million, up from the prior €130 million to €150 million range.

My Take: Buy the breakout, but keep it tactical. This is now an AI-infrastructure trade, and the stock works as long as investors believe Quake AI can turn GPUs and power capacity into real revenue.

Intel [INTC]: Premarket Move: +9%

Intel is jumping after President Trump said Apple agreed to use Intel’s foundry services to design and build chips in the U.S. The headline gives Intel another major customer win after recent foundry momentum tied to Nvidia and Elon Musk’s planned TeraFab.

This is exactly the kind of deal Intel needed. The stock is already up more than 460% over the past year, and its market cap has pushed above $600 billion. Add in Intel’s 18A-P process entering risk production, and the foundry comeback story now has more weight behind it.

My Take: Stay with the breakout and buy pullbacks, not panic spikes. Apple validation changes the foundry story, but vague chip details leave room for a headline fade if investors do not get specifics soon.

Braiin [BRAI]: Premarket Move: −6%

Braiin is slipping despite announcing a new Agentic AI customer-experience partnership with Australian enterprise BillCentral Pty Ltd. The deal gives Braiin a real deployment for its CXaaS platform, but the market is not rewarding it yet.

The issue is simple: the announcement sounds strategic, but it does not include contract value, timing, or revenue terms. Management pointed to a global CXaaS opportunity above $20 billion, but traders want company-level dollars, not just market-size language.

My Take: Avoid the dip until the company gives real economics. The partnership supports the AI story, but without deal value, this remains a press-release catalyst instead of a revenue catalyst.

Growth Watch (Sponsored)

After analyzing thousands of companies, our analysts pinpointed the 5 Stocks Set to Double based on accelerating performance, improving fundamentals, and strong technical signals.

This newly released report explains why these five could be positioned for major moves in the year ahead.

While results aren’t guaranteed, previous reports uncovered gains as high as +175%, +498%, and +673%.

Access the free report before midnight.

See the 5 Stocks Set to Double.

*This free resource is being sent by Zacks. We identify investment resources you may choose to use in making your own decisions. Use of this resource is subject to the Zacks Terms of Service.
*Past performance is no guarantee of future results. Investing involves risk. This material does not constitute investment, legal, accounting, or tax advice. Zacks Investment Research is not a licensed dealer, broker, or investment adviser.

Everything Else

  • 💼 Leadership at the top of the market is starting to shift, as investors search for the next group of stocks capable of carrying the new cycle.

  • 🚀 SpaceX’s post-IPO rally is starting to cool as investors take a harder look at the Musk premium.

  • 🛢️ Oil prices are back in focus as WTI and Brent react to shifting supply fears and Middle East risk.

  • 🐼 China’s panda bond market is getting more attention as foreign borrowers chase cheaper yuan funding.

  • 🍎 Trump says Apple will work with Intel to manufacture chips in the U.S., putting another spotlight on domestic production.

  • 🤖 Google’s Gemini co-lead Noam Shazeer is reportedly joining OpenAI, adding fresh drama to the AI talent war.

That’s all for today. Thank you for reading. If you have any feedback, please reply to this email.

Best Regards,

— Adam Garcia
Elite Trade Club

Click here to get our daily newsletter straight to your cell for free.

P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP.

Keep Reading